Tilray: Canaccord Lowers Target On Expected Adult-Use Sales Slump, Revised Hexo Deal

Earlier this week, Tilray Brands (TSX: TLRY) announced an update to their strategic alliance with Hexo Corp (TSX: HEXO) as well as amendments to HEXO’s debt. First off, Tilray announced that they have cut the conversion price on HEXO’s debt by more than 50%, dropping the price down to C$0.40 from C$0.85.

Additionally, Tilray expects that there are a number of reasons to pursue this strategic alliance between the two companies. First, they believe that there will be up to $80 million in shared cost-saving synergies and note that both companies have already “begun working on evaluating operations and production efficiencies with respect to cultivation and processing services.” HEXO will also be paying Tilray $18 million a year for advisory services.

Tilray also notes that this alliance will strengthen their product innovation, both in Canada as well as the international markets. For these two reasons, Tilray believes that purchasing this note will be “will be immediately accretive to the Company.”

Tilray Brands currently has 20 analysts covering the stock with an average 12-month price target of US$7.32, or an upside of 132%. Out of the 20 analysts, 2 have strong buy ratings, 2 have buy ratings, 13 analysts have hold ratings and the last 3 have sell ratings. The street high price target sits at US$23, which represents an upside of 630%.

In a note by Canaccord on the news, they reiterate their buy rating but lower their 12-month price target to US$7 from US$9, saying that the amended terms look good for HEXO. Though they note that the discount rate has been bumped up from 5% to 11%.

Canaccord says that Tilray will be a third-party production and processing manufacturer for HEXO, and that HEXO will source, “cannabis products for international markets exclusively from Tilray Brands.”

Canaccord has lowered their near-term estimates on Tilray as they believe that headwinds in the adult-use market “appear to be worsening on saturated market competition.” They estimate that Tilray’s adult-use brands have seen a decline of 14% quarter over quarter. As a result, they have lowered their estimates slightly, and believe that Tilray will report flat fiscal fourth-quarter results.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to the organizations discussed. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

This Gold Story Starts With Cash Flow | Gordon Robb – ESGold

Silverco Cusi Mine PEA: Bigger Isn’t Always Better

Fixing Heart Disease Tied to Sudden Death in Young People | David Elsley – Cardiol Therapeutics

Recommended

Cambria Gold To Spin Out Mt. Margaret Copper-Gold Project Into US-Focused Entity

Two Vessels Attacked Near Strait of Hormuz Within Hours as IRGC Escalates Maritime Campaign

Related News

Xebec Adsorption: Canaccord Lifts Price Target To $6

On July 6th, Xebec Adsorption (TSX: XBC) announced a master service agreement with a leading...

Thursday, July 8, 2021, 03:27:00 PM

Medmen: Canaccord Drops Price Target To $0.35 After Q1 Results

On November 9th, Medmen Enterprises (CSE: MMEN) reported their fiscal first-quarter financial results. The company...

Sunday, November 14, 2021, 10:03:00 AM

Canaccord Maintains $1.00 Price Target On Tilt Holdings

TILT Holdings (CSE: TILT) reported its second quarter revenues recently, posting revenue that was down...

Wednesday, August 26, 2020, 11:27:00 AM

CIBC: Cronos Group CEO Switch Up Is “Somewhat Surprising”

This past week, Cronos Group (TSX: CRON) (NASDAQ: CRON) announced that its Board of Directors...

Saturday, September 12, 2020, 01:45:00 PM

AMC: Analysts Call For EPS Of -$0.19 In Q2

AMC Entertainment Holdings, Inc. (NYSE: AMC) will report its second quarter financial results on August...

Wednesday, August 3, 2022, 02:21:00 PM